Cargando…
PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
BACKGROUND: Platinum-based chemotherapy is the first line option for ovarian cancer. The development of resistance to such chemotherapy results in treatment failure, while the underlying mechanisms are poorly understood. METHODS: Clinical samples were collected from Shengjing Hospital of China Medic...
Autores principales: | Bi, Fangfang, An, Yuanyuan, Sun, Tianshui, You, Yue, Yang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222667/ https://www.ncbi.nlm.nih.gov/pubmed/34178629 http://dx.doi.org/10.3389/fonc.2021.643129 |
Ejemplares similares
-
Corrigendum: PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2022) -
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
por: Kumar, Smriti, et al.
Publicado: (2011) -
SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer
por: Sun, Tianshui, et al.
Publicado: (2020) -
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2
por: Sun, Tianshui, et al.
Publicado: (2021) -
PHGDH as a mechanism for resistance in metabolically-driven cancers
por: Rathore, Richa, et al.
Publicado: (2020)